TRAVIS KING: Open Payments
NPI 1659904407 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 16 payments from 11 companies in 2025. Trend: 2023 $77 · 2024 $579 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Invivyd Inc | 1 | $150 |
| Boston Scientific Corporation | 2 | $123 |
| Baxter Healthcare | 1 | $120 |
| Novo Nordisk Inc | 2 | $51 |
| La Jolla Pharmaceutical Company | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Acist Medical Systems, Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
Products named: PEMGARDA, TISSEEL, WATCHMAN FLX, GIAPREZA, VERQUVO, VOWST, EMBLEM MRI S-ICD, JARDIANCE.
Industry payments across LA — which companies pay providers there.
